TriNetX is a health research network that connects drug discovery and development from pharmaceutical companies.
TriNetX has raised $200.0M in total funding. The most recent round was Corporate Round. The last funding was announced in April 2026.
TriNetX's investors include Regeneron, Deerfield, ITOCHU Technology Ventures, MPM Capital, Mitsui & Co.
TriNetX is headquartered in Cambridge, United States.
TriNetX is a health research network that connects drug discovery and development from pharmaceutical companies.
TriNetX is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TriNetX — Funding & Investors." VCBacked, April 2, 2026, https://www.vcbacked.co/company/trinetx. Accessed August 14, 2026.
VCBacked. (2026). TriNetX — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/trinetx
{{cite web |title=TriNetX — Funding & Investors |url=https://www.vcbacked.co/company/trinetx |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated